{"abstract": "The sale by the Swiss pharmaceutical company comes as part of an effort to focus on its larger business units.", "web_url": "https://dealbook.nytimes.com/2013/11/11/novartis-to-sell-diagnostics-unit-to-grifols-for-1-7-billion/", "snippet": "The sale by the Swiss pharmaceutical company comes as part of an effort to focus on its larger business units.", "lead_paragraph": "Novartis, the Swiss pharmaceuticals group, is selling its diagnostics business to Spanish health care company Grifols S.A. for $1.7 billion in an all-cash deal.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis to Sell Diagnostics Unit to Grifols for $1.7 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Grifols SA", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 4, "major": "N"}], "pub_date": "2013-11-11T06:40:50+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/79d23c4d-d54e-508d-bb39-8c8a27473b16", "word_count": 345, "uri": "nyt://article/79d23c4d-d54e-508d-bb39-8c8a27473b16"}